These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Modulation of tumor induced angiogenesis in Ehrlich ascites tumor. Ghosh S; Roy S; Banerjee M; Maity P J Exp Clin Cancer Res; 2004 Dec; 23(4):681-90. PubMed ID: 15743040 [TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts. Rofstad EK; Halsør EF Cancer Res; 2000 Sep; 60(17):4932-8. PubMed ID: 10987309 [TBL] [Abstract][Full Text] [Related]
11. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo. Tsukagoshi S; Saga Y; Suzuki N; Fujioka A; Nakagawa F; Fukushima M; Suzuki M Int J Oncol; 2003 May; 22(5):961-7. PubMed ID: 12684660 [TBL] [Abstract][Full Text] [Related]
12. Down-modulation of TNFSF15 in ovarian cancer by VEGF and MCP-1 is a pre-requisite for tumor neovascularization. Deng W; Gu X; Lu Y; Gu C; Zheng Y; Zhang Z; Chen L; Yao Z; Li LY Angiogenesis; 2012 Mar; 15(1):71-85. PubMed ID: 22210436 [TBL] [Abstract][Full Text] [Related]
13. Angiogenic activity and interleukin-8 content of human ovarian cancer ascites. Gawrychowski K; Skopińska-Rózewska E; Barcz E; Sommer E; Szaniawska B; Roszkowska-Purska K; Janik P; Zielinski J Eur J Gynaecol Oncol; 1998; 19(3):262-4. PubMed ID: 9641227 [No Abstract] [Full Text] [Related]
14. Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer. Curiel TJ; Cheng P; Mottram P; Alvarez X; Moons L; Evdemon-Hogan M; Wei S; Zou L; Kryczek I; Hoyle G; Lackner A; Carmeliet P; Zou W Cancer Res; 2004 Aug; 64(16):5535-8. PubMed ID: 15313886 [TBL] [Abstract][Full Text] [Related]
15. Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments. Raghavan S; Mehta P; Xie Y; Lei YL; Mehta G J Immunother Cancer; 2019 Jul; 7(1):190. PubMed ID: 31324218 [TBL] [Abstract][Full Text] [Related]
16. Defective antitumor function of monocyte-derived macrophages from epithelial ovarian cancer patients. Gordon IO; Freedman RS Clin Cancer Res; 2006 Mar; 12(5):1515-24. PubMed ID: 16533776 [TBL] [Abstract][Full Text] [Related]
17. Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice. Robinson-Smith TM; Isaacsohn I; Mercer CA; Zhou M; Van Rooijen N; Husseinzadeh N; McFarland-Mancini MM; Drew AF Cancer Res; 2007 Jun; 67(12):5708-16. PubMed ID: 17575137 [TBL] [Abstract][Full Text] [Related]
18. Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma. Bolat F; Gumurdulu D; Erkanli S; Kayaselcuk F; Zeren H; Ali Vardar M; Kuscu E Pathol Res Pract; 2008; 204(6):379-87. PubMed ID: 18343598 [TBL] [Abstract][Full Text] [Related]
19. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis. Huang S; Xie K; Bucana CD; Ullrich SE; Bar-Eli M Clin Cancer Res; 1996 Dec; 2(12):1969-79. PubMed ID: 9816156 [TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor-trap decreases tumor burden, inhibits ascites, and causes dramatic vascular remodeling in an ovarian cancer model. Byrne AT; Ross L; Holash J; Nakanishi M; Hu L; Hofmann JI; Yancopoulos GD; Jaffe RB Clin Cancer Res; 2003 Nov; 9(15):5721-8. PubMed ID: 14654557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]